BioSpace News Archive

Intrivo, a U.S.-based health-tech leader, announced today the launch of On/Go One™, a rapid COVID-19 test which recently gained Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Rondo Therapeutics today announced the closing of an oversubscribed $67 million Series A financing.

Nanomix Corporation today announced it has completed the previously announced reverse stock split of its outstanding shares of common stock at a ratio of 1-for-173.

AevisBio today announced publication of key research demonstrating 3,6’-dithiopomalidomide (3,6’-DP or AEV103) decreases neuroinflammation and mitigates cognitive decline in the presence of progressive amyloid-beta (Aβ).

Statera Biopharma, Inc. today announced submission to the U.S. Food and Drug Administration (FDA) of its pilot study protocol for STAT-205 treatment of post-acute (long-haul) COVID-19.

Generation Bio Co. announced that Geoff McDonough, M.D., president and chief executive officer, will participate in the Gene Therapy panel discussion at the 42nd Annual Cowen Health Care Conference on Wednesday, March 9 at 12:50 p.m. ET.

Avalo Therapeutics, Inc. today announced business updates and year-end financial results for 2021.

Harpoon Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to HPN217, a BCMA-targeting TriTAC ® .

Celcuity Inc. today announced its participation in the virtual Cowen 42nd Annual Health Care Conference to be held March 7-9, 2022.

Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will participate in a panel discussion on lung cancer at the Cowen 42nd Annual Health Care Conference.